4-(4-Aminophenoxy)-N-Methylpicolinamide CAS 284462-37-9 Sorafenib Tosylate Intermediate Factory High Purity

Short Description:

Chemical Name: 4-(4-Aminophenoxy)-N-Methylpicolinamide  

CAS: 284462-37-9

Appearance: Light Brown to Off-White Powder

Purity: 98.0%~101.0% (on the dried basis) (HPLC)

Intermediate of Sorafenib Tosylate (CAS: 475207-59-1) in the treatment of RCC & HCC

High Quality, Commercial Production 

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name 4-(4-Aminophenoxy)-N-Methylpicolinamide
Synonyms 4-(4-Aminophenoxy)-N-Methyl-2-Pyridinecarboxamide 
CAS Number 284462-37-9
CAT Number RF-PI166
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C13H13N3O2
Molecular Weight 243.27
Melting Point 110.0~112.0℃ 
Density 1.241 g/cm3
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Light Brown to Off-White Powder 
Purity / Analysis Method 98.0%~101.0% (on the dried basis) (HPLC)
Loss on Drying ≤0.50%
Residue on Ignition ≤0.20%
Single impurity ≤0.20%
Total impurities ≤1.0%
Heavy Metals  ≤20ppm
Test Standard Enterprise Standard
Usage Intermediate of Sorafenib Tosylate (CAS: 475207-59-1)

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

1

FAQ:

Application:

Manufacturer with High Purity and Stable Quality
Commercial Supply Sorafenib Tosylate (CAS: 475207-59-1) Related Intermediates:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methylpicolinamide CAS: 284462-37-9
4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS: 327-78-6

Sorafenib Tosylate (CAS: 475207-59-1) is a new type of multi-target antitumor drug, was developed by the German Bayer Pharmaceuticals, and displayed expansive antitumor activity in preclinical animal tests. Sorafenib is available in 200-mg tablets for oral administrationand is used in the treatment of RCC and HCC. 

  • Write your message here and send it to us